| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatic Encephalopathy | 11 | 2026 | 82 | 5.350 |
Why?
|
| Liver Failure, Acute | 8 | 2026 | 96 | 3.530 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2025 | 138 | 2.870 |
Why?
|
| Chemical and Drug Induced Liver Injury | 4 | 2025 | 142 | 2.350 |
Why?
|
| Liver | 14 | 2025 | 1799 | 2.200 |
Why?
|
| Acetaminophen | 3 | 2025 | 97 | 2.040 |
Why?
|
| Cholestasis | 8 | 2021 | 165 | 1.680 |
Why?
|
| Signal Transduction | 13 | 2025 | 4683 | 1.470 |
Why?
|
| Mice, Inbred C57BL | 17 | 2026 | 4769 | 1.430 |
Why?
|
| Microglia | 4 | 2026 | 138 | 1.360 |
Why?
|
| Thrombospondin 1 | 2 | 2020 | 22 | 1.290 |
Why?
|
| Bile Ducts | 8 | 2021 | 53 | 1.280 |
Why?
|
| Bile Acids and Salts | 3 | 2016 | 257 | 1.210 |
Why?
|
| Azoxymethane | 8 | 2026 | 14 | 1.200 |
Why?
|
| Up-Regulation | 5 | 2019 | 832 | 1.020 |
Why?
|
| Disease Models, Animal | 16 | 2026 | 4696 | 0.940 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2025 | 100 | 0.920 |
Why?
|
| Hepatocytes | 3 | 2025 | 234 | 0.890 |
Why?
|
| CD47 Antigen | 1 | 2024 | 11 | 0.890 |
Why?
|
| Schools, Medical | 1 | 2025 | 115 | 0.850 |
Why?
|
| Personnel Selection | 1 | 2025 | 79 | 0.840 |
Why?
|
| Benzamides | 3 | 2019 | 122 | 0.820 |
Why?
|
| Interviews as Topic | 1 | 2025 | 440 | 0.790 |
Why?
|
| Mice, Knockout | 7 | 2024 | 3864 | 0.740 |
Why?
|
| Glutathione | 2 | 2020 | 198 | 0.740 |
Why?
|
| Faculty, Medical | 1 | 2025 | 270 | 0.730 |
Why?
|
| Mice | 24 | 2026 | 18488 | 0.710 |
Why?
|
| Animals | 34 | 2026 | 34375 | 0.690 |
Why?
|
| Galanin | 2 | 2020 | 6 | 0.680 |
Why?
|
| Cell Death | 4 | 2024 | 237 | 0.660 |
Why?
|
| Blood-Brain Barrier | 3 | 2015 | 149 | 0.640 |
Why?
|
| Liver Cirrhosis | 6 | 2021 | 901 | 0.640 |
Why?
|
| Chemokine CCL2 | 2 | 2025 | 114 | 0.640 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2017 | 74 | 0.630 |
Why?
|
| Pyrazoles | 2 | 2019 | 358 | 0.610 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 85 | 0.590 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 39 | 0.590 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2017 | 64 | 0.580 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 468 | 0.570 |
Why?
|
| Hypothalamus | 3 | 2017 | 205 | 0.560 |
Why?
|
| Pineal Gland | 1 | 2017 | 21 | 0.530 |
Why?
|
| Carcinogens | 4 | 2019 | 129 | 0.520 |
Why?
|
| Melatonin | 1 | 2017 | 30 | 0.520 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 4 | 0.510 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 463 | 0.490 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 300 | 0.490 |
Why?
|
| Claudin-5 | 1 | 2015 | 3 | 0.460 |
Why?
|
| Encephalitis | 1 | 2016 | 120 | 0.450 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 99 | 0.450 |
Why?
|
| Capillary Permeability | 1 | 2015 | 72 | 0.450 |
Why?
|
| Inflammation | 7 | 2021 | 1492 | 0.440 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 139 | 0.440 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 329 | 0.410 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 112 | 0.410 |
Why?
|
| Neurons | 3 | 2026 | 1990 | 0.390 |
Why?
|
| Bile Ducts, Intrahepatic | 4 | 2015 | 104 | 0.380 |
Why?
|
| Oxidative Stress | 3 | 2025 | 807 | 0.380 |
Why?
|
| Cell Proliferation | 10 | 2020 | 2463 | 0.380 |
Why?
|
| Male | 26 | 2026 | 65267 | 0.380 |
Why?
|
| Homeostasis | 1 | 2016 | 713 | 0.370 |
Why?
|
| Phosphorylation | 4 | 2020 | 1571 | 0.360 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 403 | 0.320 |
Why?
|
| Morpholinos | 4 | 2017 | 9 | 0.290 |
Why?
|
| Cholangiocarcinoma | 4 | 2014 | 126 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2018 | 1151 | 0.270 |
Why?
|
| Antioxidants | 2 | 2020 | 336 | 0.260 |
Why?
|
| Rats | 7 | 2021 | 3460 | 0.260 |
Why?
|
| Bile Duct Neoplasms | 3 | 2014 | 131 | 0.250 |
Why?
|
| Ligation | 5 | 2021 | 137 | 0.250 |
Why?
|
| Apoptosis | 2 | 2025 | 1861 | 0.230 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 7 | 0.230 |
Why?
|
| Hepatic Stellate Cells | 3 | 2021 | 28 | 0.220 |
Why?
|
| Smad3 Protein | 2 | 2015 | 56 | 0.220 |
Why?
|
| Neuroprotective Agents | 1 | 2026 | 161 | 0.220 |
Why?
|
| Cell Line | 4 | 2017 | 2605 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2026 | 323 | 0.210 |
Why?
|
| Writing | 1 | 2024 | 60 | 0.210 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 82 | 0.210 |
Why?
|
| Down-Regulation | 2 | 2016 | 659 | 0.200 |
Why?
|
| Interleukin-6 | 3 | 2018 | 419 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2025 | 643 | 0.190 |
Why?
|
| DNA Damage | 1 | 2025 | 527 | 0.180 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 41 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 418 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2017 | 51 | 0.170 |
Why?
|
| Hyperplasia | 2 | 2021 | 189 | 0.170 |
Why?
|
| Disease Progression | 2 | 2025 | 2206 | 0.170 |
Why?
|
| Education, Medical | 1 | 2024 | 288 | 0.170 |
Why?
|
| Liver Regeneration | 1 | 2020 | 39 | 0.170 |
Why?
|
| Receptors, Ghrelin | 1 | 2020 | 29 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 293 | 0.160 |
Why?
|
| Receptors, LHRH | 2 | 2017 | 13 | 0.160 |
Why?
|
| Ghrelin | 1 | 2020 | 58 | 0.160 |
Why?
|
| Receptor, Galanin, Type 1 | 1 | 2020 | 1 | 0.160 |
Why?
|
| Receptor, Galanin, Type 2 | 1 | 2020 | 2 | 0.160 |
Why?
|
| Bilirubin | 2 | 2021 | 126 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 131 | 0.150 |
Why?
|
| Isoquinolines | 1 | 2019 | 42 | 0.150 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 160 | 0.150 |
Why?
|
| Protective Agents | 1 | 2019 | 36 | 0.150 |
Why?
|
| Pyridostigmine Bromide | 1 | 2018 | 12 | 0.150 |
Why?
|
| Permethrin | 1 | 2018 | 7 | 0.150 |
Why?
|
| Necrosis | 1 | 2019 | 195 | 0.140 |
Why?
|
| Keratin-19 | 2 | 2015 | 3 | 0.140 |
Why?
|
| Thioacetamide | 1 | 2018 | 3 | 0.140 |
Why?
|
| Persian Gulf Syndrome | 1 | 2018 | 16 | 0.140 |
Why?
|
| DEET | 1 | 2018 | 26 | 0.140 |
Why?
|
| Probiotics | 1 | 2021 | 231 | 0.140 |
Why?
|
| Phagocytosis | 1 | 2019 | 191 | 0.140 |
Why?
|
| Antibodies | 1 | 2019 | 357 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 518 | 0.130 |
Why?
|
| Pyrroles | 1 | 2019 | 186 | 0.130 |
Why?
|
| Hormone Antagonists | 1 | 2017 | 45 | 0.130 |
Why?
|
| Central Nervous System Depressants | 1 | 2017 | 22 | 0.130 |
Why?
|
| Pyridines | 1 | 2019 | 260 | 0.130 |
Why?
|
| Brain | 3 | 2021 | 3239 | 0.130 |
Why?
|
| Receptors, Galanin | 1 | 2017 | 1 | 0.130 |
Why?
|
| Acute-Phase Reaction | 1 | 2017 | 7 | 0.130 |
Why?
|
| Infusions, Intraventricular | 1 | 2016 | 11 | 0.130 |
Why?
|
| Regeneration | 1 | 2019 | 231 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 98 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2021 | 381 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 27 | 0.120 |
Why?
|
| Texas | 1 | 2025 | 3622 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 341 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 165 | 0.120 |
Why?
|
| Cholic Acid | 1 | 2015 | 19 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 156 | 0.120 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2015 | 32 | 0.120 |
Why?
|
| Cholestyramine Resin | 1 | 2015 | 13 | 0.120 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2015 | 25 | 0.120 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2015 | 8 | 0.120 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2015 | 8 | 0.120 |
Why?
|
| Secretin | 1 | 2015 | 12 | 0.120 |
Why?
|
| Triterpenes | 1 | 2015 | 23 | 0.120 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2015 | 10 | 0.120 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 22 | 0.120 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2015 | 20 | 0.120 |
Why?
|
| Receptors, Somatostatin | 1 | 2015 | 55 | 0.110 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 48 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2017 | 350 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2015 | 28 | 0.110 |
Why?
|
| Symporters | 1 | 2015 | 74 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2020 | 900 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 328 | 0.110 |
Why?
|
| Body Weight | 2 | 2021 | 990 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2015 | 68 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 482 | 0.110 |
Why?
|
| Cytokines | 2 | 2021 | 1348 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 421 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 272 | 0.110 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2014 | 34 | 0.110 |
Why?
|
| Neuroglia | 1 | 2016 | 223 | 0.110 |
Why?
|
| Deoxycholic Acid | 1 | 2014 | 14 | 0.110 |
Why?
|
| Neprilysin | 1 | 2014 | 20 | 0.110 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2014 | 19 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2025 | 6494 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2016 | 769 | 0.110 |
Why?
|
| Autopsy | 1 | 2014 | 119 | 0.110 |
Why?
|
| Substance P | 1 | 2014 | 32 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2014 | 39 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2971 | 0.100 |
Why?
|
| Body Temperature | 1 | 2014 | 128 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 64 | 0.100 |
Why?
|
| Microvessels | 1 | 2014 | 65 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2363 | 0.100 |
Why?
|
| Cholesterol | 1 | 2016 | 541 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2018 | 562 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 203 | 0.100 |
Why?
|
| Glycine | 1 | 2014 | 165 | 0.100 |
Why?
|
| Quinazolines | 1 | 2014 | 181 | 0.100 |
Why?
|
| Choledochal Cyst | 1 | 2012 | 9 | 0.100 |
Why?
|
| Monoamine Oxidase | 1 | 2012 | 19 | 0.100 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 314 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 56 | 0.090 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2011 | 7 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1024 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 131680 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 566 | 0.090 |
Why?
|
| DNA | 1 | 2017 | 1442 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2020 | 103 | 0.090 |
Why?
|
| Biomarkers | 2 | 2018 | 3405 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1617 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 2969 | 0.080 |
Why?
|
| Time Factors | 3 | 2017 | 6279 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2014 | 3454 | 0.080 |
Why?
|
| Female | 6 | 2025 | 71186 | 0.080 |
Why?
|
| Corticosterone | 2 | 2017 | 53 | 0.060 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2025 | 59 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 2437 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 2015 | 229 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2025 | 1086 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2026 | 1316 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 240 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2014 | 714 | 0.040 |
Why?
|
| Ammonium Compounds | 1 | 2021 | 1 | 0.040 |
Why?
|
| Inositol | 1 | 2021 | 15 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 31 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 3673 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2020 | 73 | 0.040 |
Why?
|
| Transaminases | 1 | 2020 | 36 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2021 | 66 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1021 | 0.040 |
Why?
|
| Leptin | 1 | 2021 | 219 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2021 | 309 | 0.040 |
Why?
|
| Middle Aged | 2 | 2025 | 28889 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 372 | 0.040 |
Why?
|
| Glutamine | 1 | 2021 | 202 | 0.040 |
Why?
|
| Immobilization | 1 | 2018 | 23 | 0.040 |
Why?
|
| CD11b Antigen | 1 | 2018 | 35 | 0.040 |
Why?
|
| Metabolome | 1 | 2021 | 329 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 517 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2021 | 510 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 725 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 337 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2021 | 1104 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 338 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1989 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2015 | 10 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 60 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 72 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 881 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 420 | 0.030 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 230 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Occludin | 1 | 2014 | 19 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 275 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 37 | 0.030 |
Why?
|
| Aminoquinolines | 1 | 2014 | 36 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1502 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 64 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 120 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 239 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 835 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2012 | 37 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 960 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 233 | 0.020 |
Why?
|
| 1-Naphthylisothiocyanate | 1 | 2011 | 2 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2011 | 64 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 136 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2011 | 40 | 0.020 |
Why?
|
| Serotonin | 1 | 2012 | 212 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 291 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 256 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 224 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 443 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 536 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1626 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 854 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 530 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1218 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2568 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2012 | 777 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21261 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 31719 | 0.010 |
Why?
|